par Michiels, Sandra ;Bron, Dominique ;Crombez, Patrick;Meuleman, Nathalie ;Kirakoya, Fati ;Tricas-Sauras, Sandra
Editeur scientifique Michiels, Sandra ;Bron, Dominique ;Crombez, Patrick;Meuleman, Nathalie ;Kirakoya, Fati ;Tricas-Sauras, Sandra
Référence Annual Meeting of the European Society for Blood and Marrow Transplantation(45th: 2019-03-26: Frankfurt, Germany), NO009 A prospective approach of migrants and ethnic minorities in order to overcome poor adherence and to guarantee an equal access to innovative transplant procedures, Bone Marrow Transplantation, Vol. 54, page (620–634)
Publication Publié, 2019-03-26
Abstract de conférence
Résumé : Background: Patients with malignant hemopathies are increasingly treated by Oral Anticancer Medications (OAMs), including for bridging to transplant. The control of outpatients' adherence to treatment is a real challenge for clinicians. It has been demonstrated that poor adherence impacts the quality of response to treatment and the risk of relapse. Recent studies underline the link between adherence and patients' knowledge and beliefs, and also patient-clinician interactions. Nonetheless, a key population group seems to be forgotten from research: Migrants and Ethnic Minorities (MEMs). MEMs have been identified as one of the most vulnerable groups in health care provision and recent findings underline considerable disparities and difficulties in communication between doctors and patients from different cultural and/or ethnic backgrounds. It seems therefore reasonable to anticipate a higher risk of poor adherence among MEMs.Methods: Between 2012 and 2017, we conducted a 2 consecutive questionnaire-based survey which investigated 24 Healthcare Professionals' (HCPs) comfort and ability to take care for MEMs and 58 MEMs patients' satisfaction regarding their experience of transplantation. Subsequently, we conducted a scoping review of the scientific literature regarding MEMs' adherence to OAMs.Results: First survey revealed that 76% of HCPs had difficulties to care for foreign patients and that the sole presence of Intercultural Mediation (IM) services was not enough to ensure a high quality of care for this population. Also, patients' satisfaction survey allows to highlight the strong presence of MEMs in our regular patients. Half of the participants were born abroad and 40% did not have French or Dutch as their mother language. Among those speaking little or not at all French, only a few were informed about the existence of IM services. MEMs´ Satisfaction score was not lower. The results of the scoping review confirm unequal situations for MEMs in cancer care and highlights gaps in knowledge and research concerning the issue of MEMs' adherence. In order to reduce this gap, we created the MADESIO project, a two-phase approach. First phase will consist on developing some specific organizational supports, translating documents, facilitating the development of cultural competences in our staff and providing relevant tools to overcome urgent missing access to the Adherence Consultation and subsequent follow-up for MEMs. By using a mixed method approach, the second phase will evaluate MEMs' adherence and also explore the potential underlying mechanisms of poor-adherence for this population.Conclusions: European migration has continued to grow rapidly in recent years. To eliminate the burden of health disparities and to ensure the best outcomes in MEMs with hematological malignancies, a collaborative approach between research fellows and clinicians is urgently needed. MADESIO's prospective approach of MEMs'care will contribute to overcome poor adherence. Also, we hope guarantee an equal access to innovative transplant procedures with an emphasis on inclusive care. Finally, the findings from research phase will be highly valuable for healthcare services to facilitate the development of patient tailored complex interventions and to guide providers in choosing best suited strategies to address and ultimately improve medication adherence.